Cyclacel Pharmaceuticals, Inc.

CYCC · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$3,137$3,378$18,345$36,559
Short-Term Investments$0$0$0$0
Receivables$237$2,933$4,664$3,727
Inventory$0$0$0$577
Other Curr. Assets$300$1,133$1,402$79
Total Curr. Assets$3,674$7,444$24,411$40,942
Property Plant & Equip (Net)$8$102$174$94
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$411$1,259$3,465$1,551
Total NC Assets$419$1,361$3,639$1,645
Other Assets$1$0$0$0
Total Assets$4,094$8,805$28,050$43,136
Liabilities
Payables$4,599$3,543$2,561$2,117
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$1,669$4,618$4,950$3,296
Total Curr. Liab.$6,268$8,161$7,511$5,413
LT Debt$0$37$106$30
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$37$106$30
Other Liabilities$0$0$0$0
Cap. Leases$0$37$106$30
Total Liabilities$6,268$8,198$7,617$5,443
Equity
Pref Stock$0$0$4,494$0
Common Stock$9$1$1$10
Retained Earnings-$439,494-$428,282-$405,727-$384,529
AOCI-$891-$908-$1,316-$748
Other Equity$438,202$429,796$422,981$422,960
Total Equity-$2,174$607$20,433$37,693
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$4,094$8,805$28,050$43,136
Net Debt-$3,137-$3,341-$18,239-$36,529